Using hypnosis to help manage anxiety in hematologic cancer patients
Official title: Hypnosis: a Path to Appeasement
Run by Hospices Civils de Lyon · NCT05942885 · Data updated 2026-11-12
This study tests whether hypnosis can help adults with certain blood cancers feel less anxious about their diagnosis and treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Lyon, Pierre-Bénite) |
| Status | Recruiting |
| Started | October 30, 2023 |
| Main results expected | April 30, 2026 |
| Study ends | July 30, 2026 |
| Registry record updated | September 11, 2025 |
| Trial ID | NCT05942885 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with a recent diagnosis of diffuse large cell B-cell lymphoma or follicular lymphoma and elevated anxiety levels.
✕Probably not a fit
Patients who are not fluent in French or those with legal restrictions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study explores the use of hypnosis as a therapeutic tool to help patients with hematologic cancers, specifically diffuse large cell B-cell lymphoma and follicular lymphoma, manage anxiety related to their diagnosis and treatment. Patients over 18 years old who are fluent in French and have a specific anxiety score will be referred for hypnotherapy. The effectiveness of hypnosis in reducing anxiety over time will be measured using the Hospital Anxiety and Depression Scale (HADS). This approach aims to enhance the quality of life for patients undergoing treatment for these cancers.
Why it matters
Potential benefit: If successful, this approach could significantly reduce anxiety levels in patients with hematologic cancers, improving their overall quality of life during treatment.
How similar studies have gone: While hypnosis has shown effectiveness in improving quality of life in breast cancer patients, this specific application in hematologic cancers is novel and has not been extensively studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years old, fluent in French. * Patients starting hypnotherapy for anxiety disorders. * Anxiety score on the HADS scale (Hospital Anxiety and Depression Scale) greater than or equal to 8/21 * Patients with diffuse large cell B-cell lymphoma or follicular lymphoma, whatever the stage of the disease. * Diagnosis announcement less than 2 months old Exclusion Criteria: * Persons deprived of their liberty by a judicial or administrative decision * Adults subject to a legal protection measure
Where it's running
-
Service MB1 - Hôpital Lyon Sud - HCL
Lyon, Pierre-Bénite, France Recruiting
Study contacts
- Principal investigator: Thomas BERT — Hospices Civils de Lyon
- Study coordinator: Thomas BERT
- Email: thomas.bert01@chu-lyon.fr
- Phone: 04.78.86.43.45
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual reality to improve comfort for adults with hematologic cancer in hospital
Researchers are testing whether short VR experiences can help comfort and mood for adults with blood cancers who are staying in the hospital for at least 15 days.
-
Genetics of Blood Cancers in the U.S. population
This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.
-
Venetoclax added to reduced-intensity conditioning for combined stem cell and kidney transplant
This trial tests whether adding venetoclax to a reduced-intensity conditioning regimen is safe for adults with blood cancers who are receiving a combined stem cell and kidney transplant from a matched or partially matched donor.
-
Using exercise and nutrition to reduce CAR‑T neurotoxicity in adults with blood cancers
This test will try whether a structured exercise program alone or combined with nutrition advice can lower the risk or severity of neurotoxicity after CAR‑T therapy in adults (18–80) with hematologic cancer.
-
Florida ASCENT Program
This project will test whether combining the MyCarePulse EHR platform with ASCENT patient navigators helps adults with recent cancer diagnoses in Florida improve food security, diet quality, and confidence in healthy eating compared with standard care.
-
18F-G1 PET/CT to see early immunotherapy response in solid tumors and blood cancers
We are testing if the 18F-G1 PET/CT scan can help tell early on whether people with solid tumors or blood cancers will respond to immunotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.